Drug reference
ferric hydroxy polymaltose
Iron preparation · Haematinic
Iron preparationHaematinicATC B03AC
CDSCO approvedATC B03AC
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
C
FDA category + note
Mechanism
Forms a complex that releases little free iron in the gut lumen, intended for direct absorption from the intestines.
Indications
Iron deficiency anaemia
Pharmacokinetics
Bioavailability
poor efficacy in treating iron deficiency anaemia in humans; therapeutic efficacy is questionable
Side effects
Common
no metallic tastegood g.i. tolerabilityminimal g.i. irritation
Pregnancy & lactation
Pregnancy
C
Related guidelines
Iron deficiency anaemia in pregnancy
FOGSI · Obstetrics & Gynaecology · 2017
Iron deficiency anaemia in adults
ICMR · Hematology · 2023
Iron deficiency anaemia in pregnancy
ICMR · Obstetrics & Gynaecology · 2022
Sickle cell disease
ASH · Haematology · 2020
Blood transfusion in obstetrics and gynaecology
FOGSI · Obstetrics & Gynaecology · 2024
Other Iron preparation drugs
Ask House about ferric hydroxy polymaltose
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team